Enristomig
Based on 1 Customer Validation
Enristomig (ES-101) is a multispecific antibody. Enristomig is both a PD-L1 antagonist and a conditional agonist of 4-1BB. Enristomig can be used for research on PD-L1 expressing tumors.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 98.447%
- CAS No.: 2539845-73-1
- 분자량:101.884 kDa
-
보관:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
IC50 & Target
TNFRSF9 & CD274
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
신청
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized 4-1BB/TNFRSF9 Protein, Human (HEK293, His, HY-P70678) can bind Enristomig. The EC50 for this effect is 4.611 ng/mL. -
Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Enristomig. The EC50 for this effect is 2.063 ng/mL.
Product Details
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Purity
98.447%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
선적
Shipping with dry ice.
순도&문서
References
[1]. Enristomig
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)